中航機電(002013.SZ):擬以“新設合併”方式將慶安製冷與機電三洋進行整合
格隆匯 12 月 23日丨中航機電(002013.SZ)公佈,公司於2020年12月23日召開第七屆董事會第三次會議,審議通過《關於子公司所屬西安慶安製冷設備股份有限公司重組暨關聯交易的議案》,同意子公司慶安集團有限公司(“慶安公司”)擬將控股的西安慶安製冷設備股份有限公司(“慶安製冷”)與瀋陽中航機電三洋製冷設備有限公司(“機電三洋”)進行重組,目前籌劃的重組方式為:以“新設合併”方式將慶安製冷與機電三洋進行整合。
此次重組完成後,預計慶安製冷不再納入慶安集團合併報表範圍內。此次重組有利於公司進一步聚焦主業,提升上市公司資產質量及持續盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.